Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat

Christopher T. Banek, Madeline M. Gauthier, Daniel C. Baumann, Dusty Van Helden, Ninitha Asirvatham-Jeyaraj, Angela Panoskaltsis-Mortari, Gregory D. Fink, John W. Osborn

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Recent preclinical studies show renal denervation (RDNx) may be an effective treatment for hypertension; however, the mechanism remains unknown. We have recently reported total RDNx (TRDNx) and afferent-selective RDNx (ARDNx) similarly attenuated the development of deoxycorticosterone acetate (DOCA)-salt hypertension. Whereas TRDNx abolished renal inflammation, ARDNx had a minimal effect despite an identical antihypertensive effect. Although this study established that ARDNx attenuates the development of DOCA-salt hypertension, it is unknown whether this mechanism remains operative once hypertension is established. The current study tested the hypothesis that TRDNx and ARDNx would similarly decrease mean arterial pressure (MAP) in the DOCA-salt hypertensive rat, and only TRDNx would mitigate renal inflammation. After 21 days of DOCA-salt treatment, male Sprague-Dawley rats underwent TRDNx (n = 16), ARDNx (n = 16), or Sham (n = 14) treatment and were monitored for 14 days. Compared with baseline, TRDNx and ARDNx decreased MAP similarly (TRDNx -14 ± 4 and ARDNx -15 ± 6 mmHg). After analysis of diurnal rhythm, rhythm-adjusted mean and amplitude of night/day cycle were also reduced in TRDNx and ARDNx groups compared with Sham. Notably, no change in renal inflammation, injury, or function was detected with either treatment. We conclude from these findings that: 1) RDNx mitigates established DOCA-salt hypertension; 2) the MAP responses to RDNx are primarily mediated by ablation of afferent renal nerves; and 3) renal nerves do not contribute to the maintenance of renal inflammation in DOCA-salt hypertension.

Original languageEnglish (US)
Pages (from-to)R883-R891
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Issue number6
StatePublished - Jun 2018

Bibliographical note

Funding Information:
This work was supported by National Heart, Lung, and Blood Institute (NHLBI) R01 Grant HL-116476 (J. W. Osborn and G. D. Fink). C. T. Banek was supported by NHLBI T32 Training Grant 2T32-HL-7741–21 (D. Ingbar) and by American Heart Association Postdoctoral Fellowship 17POST33661003 (C.T. Banek).

Publisher Copyright:
© 2018 American Physiological Society. All rights reserved.


  • Deoxycorticosterone acetate-salt
  • Renal nerves
  • Sympathetic nervous system


Dive into the research topics of 'Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat'. Together they form a unique fingerprint.

Cite this